316 related articles for article (PubMed ID: 7696203)
1. Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice.
DiCosmo BF; Picarella D; Flavell RA
Int Immunol; 1994 Dec; 6(12):1829-37. PubMed ID: 7696203
[TBL] [Abstract][Full Text] [Related]
2. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice.
Moritani M; Yoshimoto K; Tashiro F; Hashimoto C; Miyazaki J; Ii S; Kudo E; Iwahana H; Hayashi Y; Sano T
Int Immunol; 1994 Dec; 6(12):1927-36. PubMed ID: 7696210
[TBL] [Abstract][Full Text] [Related]
3. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
4. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.
Kay TW; Parker JL; Stephens LA; Thomas HE; Allison J
J Immunol; 1996 Oct; 157(8):3688-93. PubMed ID: 8871671
[TBL] [Abstract][Full Text] [Related]
5. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
Stephens LA; Kay TW
Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice.
Akashi T; Nagafuchi S; Anzai K; Kondo S; Kitamura D; Wakana S; Ono J; Kikuchi M; Niho Y; Watanabe T
Int Immunol; 1997 Aug; 9(8):1159-64. PubMed ID: 9263013
[TBL] [Abstract][Full Text] [Related]
8. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice.
Robles DT; Eisenbarth GS; Dailey NJ; Peterson LB; Wicker LS
Diabetes; 2003 Mar; 52(3):882-6. PubMed ID: 12606534
[TBL] [Abstract][Full Text] [Related]
9. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
10. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
[TBL] [Abstract][Full Text] [Related]
11. E expression is needed on both bone marrow derived cells and thymic epithelium to increase IL-4 production and achieve protection in NOD bone marrow chimeras.
Brenden N; Rietz C; Böhme J
Cytokine; 1999 Oct; 11(10):766-72. PubMed ID: 10525315
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of TNF-alpha and IFN-gamma mRNA expression in islets and spleen of NOD mice.
Ventura-Oliveira D; Vilella CA; Zanin ME; Castro GM; Moreira Filho DC; Zollner RL
Braz J Med Biol Res; 2002 Nov; 35(11):1347-55. PubMed ID: 12426635
[TBL] [Abstract][Full Text] [Related]
13. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
Balasa B; Lee J; Sarvetnick N
Cell Immunol; 1999 May; 193(2):170-8. PubMed ID: 10222059
[TBL] [Abstract][Full Text] [Related]
14. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
[TBL] [Abstract][Full Text] [Related]
15. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
De Aizpurua HJ; French MB; Chosich N; Harrison LC
J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
[TBL] [Abstract][Full Text] [Related]
16. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.
Wong FS; Visintin I; Wen L; Granata J; Flavell R; Janeway CA
J Exp Med; 1998 Jun; 187(12):1985-93. PubMed ID: 9625758
[TBL] [Abstract][Full Text] [Related]
17. Development of insulitis and diabetes in B cell-deficient NOD mice.
Yang M; Charlton B; Gautam AM
J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
[TBL] [Abstract][Full Text] [Related]
18. Alleviation of insulitis in NOD mice is associated with expression of transgenic MHC E molecules on primary antigen-presenting cells.
Pilström B; Böhme J
Immunology; 1997 Apr; 90(4):483-8. PubMed ID: 9176099
[TBL] [Abstract][Full Text] [Related]
19. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
Liu F; Yu M; Zhu Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
[TBL] [Abstract][Full Text] [Related]
20. Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice.
Picarella DE; Kratz A; Li CB; Ruddle NH; Flavell RA
J Immunol; 1993 May; 150(9):4136-50. PubMed ID: 7682590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
